Key Points
- CFO Alexis Desieno sold 8,607 shares on Jan. 5 at an average price of $1.17, trimming her stake by 4.10% to 201,159 shares (worth ~ $235,356 after the sale).
- Shares opened at $1.24 (up 10.7%), trading in a one‑year range of $0.85–$4.05 with a market cap of about $67M; the company beat EPS expectations for the quarter (−$0.07 vs. −$0.15) but missed revenue and remains unprofitable with negative net margin and ROE.
- Analysts maintain a cautious view with a consensus rating of "Reduce" and a consensus target price of $2.25, following recent downgrades and mixed analyst coverage.
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO Alexis Desieno sold 8,607 shares of the company's stock in a transaction on Monday, January 5th. The stock was sold at an average price of $1.17, for a total value of $10,070.19. Following the transaction, the chief financial officer directly owned 201,159 shares in the company, valued at approximately $235,356.03. The trade was a 4.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Cardlytics Stock Up 10.7%
Cardlytics stock opened at $1.24 on Tuesday. Cardlytics, Inc. has a 1-year low of $0.85 and a 1-year high of $4.05. The business has a fifty day moving average price of $1.29 and a 200-day moving average price of $1.59. The company has a debt-to-equity ratio of 2.87, a current ratio of 1.14 and a quick ratio of 1.14. The stock has a market capitalization of $67.03 million, a price-to-earnings ratio of -0.59, a PEG ratio of 0.18 and a beta of 1.05.
Cardlytics (NASDAQ:CDLX - Get Free Report) last announced its earnings results on Wednesday, November 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.08. Cardlytics had a negative return on equity of 235.70% and a negative net margin of 44.12%.The company had revenue of $52.03 million for the quarter, compared to analyst estimates of $56.64 million. Equities research analysts forecast that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the stock. Weiss Ratings reiterated a "sell (d-)" rating on shares of Cardlytics in a research note on Monday, December 29th. Wall Street Zen downgraded shares of Cardlytics from a "hold" rating to a "sell" rating in a research note on Saturday, November 8th. Three research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus target price of $2.25.
View Our Latest Analysis on Cardlytics
Hedge Funds Weigh In On Cardlytics
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Bank of America Corp DE raised its position in Cardlytics by 262.7% during the 3rd quarter. Bank of America Corp DE now owns 1,632,786 shares of the company's stock worth $3,968,000 after buying an additional 1,182,593 shares during the last quarter. Quinn Opportunity Partners LLC increased its stake in shares of Cardlytics by 900.0% in the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company's stock worth $2,673,000 after acquiring an additional 990,000 shares during the period. Citizens Financial Group Inc. RI purchased a new position in shares of Cardlytics during the third quarter worth $1,260,000. UBS Group AG raised its holdings in shares of Cardlytics by 112.5% during the third quarter. UBS Group AG now owns 458,066 shares of the company's stock worth $1,113,000 after purchasing an additional 242,536 shares during the last quarter. Finally, Lane Generational LLC boosted its holdings in Cardlytics by 28.0% in the second quarter. Lane Generational LLC now owns 780,083 shares of the company's stock valued at $1,283,000 after purchasing an additional 170,480 shares during the last quarter. Institutional investors and hedge funds own 68.10% of the company's stock.
Cardlytics Company Profile
(
Get Free Report)
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers' online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics' offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
